Does Kefir Raise or Lower Cholesterol?

Kefir appears to modestly lower total and LDL cholesterol in most human trials, but the effect is not dramatic and depends heavily on who is drinking it, what kind of kefir it is, and how long they keep it up. Several small clinical trials have reported drops in LDL cholesterol ranging from roughly 5 to 10 mg/dL over 8 to 12 weeks, while at least one well-controlled trial in men with high cholesterol found no difference between kefir and plain milk. The picture that emerges is more nuanced than kefir fans or skeptics tend to acknowledge, and the mechanisms behind it involve some genuinely interesting biology.

What Human Trials Actually Show

The clinical evidence on kefir and cholesterol is spread across a handful of small trials, none of them large enough to settle the question on their own. In women with metabolic syndrome, daily kefir consumption lowered LDL cholesterol, non-HDL cholesterol, triglycerides, and oxidized LDL while raising HDL cholesterol.¹ A trial in overweight or obese premenopausal women found that after eight weeks, the kefir group had significantly lower total cholesterol (by about 10 mg/dL), LDL cholesterol (by about 10 mg/dL), and non-HDL cholesterol (by about 12 mg/dL) compared to a control group that added no dairy.² And a pilot study in men found that traditionally fermented kefir reduced LDL cholesterol along with markers of vascular inflammation, while a commercial kefir product did not produce the same benefits.³

These results sound encouraging, but they come with a catch that the next section explores in detail: in the trials that compared kefir head-to-head with regular milk, the two performed about the same.

The Milk Comparison Problem

Here is where the kefir story gets complicated. In the trial of overweight premenopausal women just mentioned, the kefir group’s lipid improvements looked impressive against a no-dairy control. But the study also had a low-fat milk group, and the milk drinkers saw nearly identical improvements. The difference between the kefir and milk groups was not statistically significant.² In other words, adding dairy to the diet improved cholesterol numbers, but kefir did not clearly outperform plain milk.

An earlier crossover trial in hyperlipidemic men produced an even more deflating result. After a period of daily kefir consumption, total cholesterol, LDL cholesterol, and HDL cholesterol were all essentially unchanged compared to a period of plain milk consumption. Even cholesterol synthesis rates, measured directly, showed no difference.⁴ This trial is often cited by skeptics as proof that kefir’s cholesterol benefits are a myth, and it is a valid data point. But it studied only men, used a relatively short intervention, and the kefir used may have differed from traditionally fermented products.

The broader pattern across fermented dairy research may help explain these mixed results. A review of the evidence on full-fat and fermented dairy products found that yogurt, cheese, and similar foods do not have the harmful effects on blood lipids that were once predicted based on their saturated fat content, and may actually protect against cardiovascular disease.⁵ Fermentation changes the dairy matrix in ways that alter how fats and other nutrients interact with your body. This means kefir’s benefits, where they exist, may partly reflect a general fermented-dairy advantage rather than something unique to kefir’s microbes.

How Kefir’s Microbes Could Lower Cholesterol

Even if the clinical picture is mixed, the biological mechanisms that could explain a cholesterol-lowering effect are surprisingly well studied, mostly in laboratory and animal models. Understanding these helps make sense of why the effect shows up in some trials and not others.

The most researched mechanism involves bile salt hydrolase, an enzyme produced by several lactic acid bacteria found in kefir grains. Your liver uses cholesterol to make bile acids, which it sends to your intestines to help digest fat. Normally, most of those bile acids get recycled back to the liver. But bile salt hydrolase breaks apart the chemical bond that allows bile acids to be efficiently reabsorbed. The deconjugated bile acids are more likely to leave your body through feces, which forces your liver to pull cholesterol out of your blood to make fresh bile acids. In a study using a Lactobacillus strain isolated from kefir grains, cells that had been adapted to bile stress showed a more than two-fold increase in bile salt hydrolase activity and drove significantly lower total and non-HDL cholesterol levels in animal models, with fecal bile acid excretion increasing roughly five-fold compared to unadapted cells.⁶ Similar bile-acid-driven cholesterol reduction has been demonstrated with other Lactobacillus strains, where supplementation led to lower plasma total cholesterol, LDL, and triglycerides in rats on high-cholesterol diets, alongside greater fecal bile acid output.⁷

A second pathway involves short-chain fatty acids, which are produced when gut bacteria ferment fiber and other substrates. These molecules appear to slow down cholesterol production in the liver itself. In animal studies, feeding a short-chain fatty acid mixture lowered the rate at which the liver synthesized cholesterol, which in turn reduced circulating cholesterol levels.⁸ Kefir’s fermentation process and its influence on gut bacteria could plausibly increase short-chain fatty acid production, though this link has not been cleanly demonstrated in human kefir trials.

Kefir also contains kefiran, a unique polysaccharide produced by the grain’s microbial community. Animal research has shown that kefiran can suppress blood pressure increases and reduce serum cholesterol when animals consume excessive dietary cholesterol.⁹ Whether enough kefiran survives digestion in humans to produce a meaningful effect remains unclear.

Who Might Benefit Most

The trials that did find cholesterol improvements share a common thread: the participants tended to already have metabolic problems. People with metabolic syndrome, elevated baseline LDL, or obesity seemed to respond better than those with mildly elevated or normal cholesterol. This makes biological sense. If your cholesterol metabolism is already under strain, introducing beneficial microbes that push bile acids out of circulation or reduce liver fat synthesis gives the system more room to improve. If your numbers are already well-managed, there is less room to move the needle.

A trial in metabolic syndrome patients found that kefir increased apolipoprotein A1, a protein associated with HDL and cardiovascular protection, by about 3.4% over 12 weeks. In a subgroup of participants whose LDL exceeded 130 mg/dL, kefir consumption reduced LDL cholesterol by about 7.6% and apolipoprotein B by about 5.4% compared to baseline.¹⁰ But even in this trial, those improvements did not reach statistical significance when compared with a milk-drinking control group. The effect seems real for the individual but hard to separate from what regular dairy consumption itself provides.

For people with healthy cholesterol levels, the evidence does not support expecting kefir to drive numbers meaningfully lower. The existing trials suggest it is unlikely to raise cholesterol either, given that fermented dairy generally does not worsen lipid profiles despite containing saturated fat.⁵

How Much You Need and For How Long

Not all kefir doses and timelines do the same thing. A recent overview of human clinical trials found a useful pattern: gut-related benefits like improved stool frequency and microbiome diversity can show up within four weeks at relatively modest volumes of about 200 to 250 mL per day. But metabolic effects, including changes to cholesterol, inflammatory markers, and appetite regulation, generally required higher daily volumes of 300 to 600 mL over six to twelve weeks.¹¹ That means a splash of kefir in your morning smoothie once in a while is unlikely to do anything detectable for your cholesterol. The trials that found improvements typically used something closer to two cups a day, consumed consistently for at least two months.

This is a practical barrier. Two cups of kefir daily adds calories and cost, and not everyone tolerates that volume well, particularly people who are lactose intolerant. Kefir does contain less lactose than plain milk because its bacteria partially digest it during fermentation, but it is not lactose-free.

Traditional Grain-Fermented Versus Commercial Kefir

One of the more interesting findings in recent research is that not all kefir products are created equal. Kefir grains, those rubbery cauliflower-like clusters, harbor a diverse ecosystem of dozens of bacterial and yeast species living in a matrix of kefiran. Commercial kefir products are often made with defined starter cultures containing far fewer species. The pilot study comparing the two directly found that traditionally fermented kefir reduced LDL cholesterol and vascular inflammation markers, while the commercial product actually increased a pro-inflammatory marker.³

Laboratory work helps explain why. When selected kefir starter culture bacteria were tested for their ability to bind cholesterol under simulated digestive conditions, their performance dropped compared to what they could do in a laboratory growth medium. Yeast cultures also showed greater cholesterol binding in lab settings but limited survival in digestive models.¹² The richer microbial diversity in grain-fermented kefir may give it a resilience advantage, with more species able to survive the acid and bile of the gut and deliver their enzymatic activity where it counts. This is a genuinely important detail for anyone hoping to use kefir for health purposes: the bottle from the supermarket and the jar from someone’s kitchen counter may be fundamentally different products.

Effects on the Gut Itself

Kefir’s relationship with cholesterol does not end at the bile acid pathway. Research suggests that kefir-derived peptides can strengthen the intestinal barrier by increasing tight-junction proteins like claudin-1 and occludin, which reduces gut permeability. A leaky gut allows bacterial toxins called lipopolysaccharides to enter the bloodstream, triggering systemic inflammation that worsens metabolic dysfunction, including lipid abnormalities.¹³ By shoring up the gut lining, kefir may reduce a driver of the chronic low-grade inflammation that contributes to high cholesterol and atherosclerosis in the first place.

A randomized trial in metabolic syndrome patients that tracked gut microbiota composition found that regular kefir consumption significantly increased the relative abundance of Actinobacteria, a phylum that includes several beneficial Bifidobacterium species. However, other major bacterial groups did not change significantly.¹⁴ The microbiome shifts from kefir consumption are real but modest, at least with the tools currently used to measure them. Whether those shifts are the cause of the lipid improvements, or just a marker that something is changing in the gut, is still unclear.

Liver Fat and Broader Metabolic Effects

Some of the strongest evidence for kefir’s effects on lipid metabolism comes from animal studies on liver fat, which is worth noting because fatty liver disease and high cholesterol are closely linked. In genetically obese mice, kefir consumption reduced both triglyceride and total cholesterol content in the liver while also decreasing markers of liver damage.¹⁵ Mice on a high-fat diet that received kefir ended up weighing significantly less and had markedly lower liver lesion scores, with kefir upregulating genes involved in fatty acid burning in both liver and fat tissue.¹⁶

In a rat model of non-alcoholic steatohepatitis, the more advanced inflammatory stage of fatty liver disease, kefir treatment significantly reduced total cholesterol, triglycerides, and LDL cholesterol in the blood while increasing HDL cholesterol. These improvements were even greater when kefir was given before the disease was induced, suggesting a preventive role.¹⁷ Translating animal results to human expectations is always risky, and the doses used in animal studies are often proportionally higher than what a person would drink. But these studies do point to liver fat as a promising mechanism by which kefir could influence circulating cholesterol.

Kefir’s Effects Beyond Cholesterol Numbers

Cholesterol numbers on a lab report only tell part of the cardiovascular risk story. Oxidized LDL, the chemically modified form of LDL cholesterol that actually burrows into artery walls and triggers plaque formation, may be a more direct marker of danger than total LDL alone. Research using kefir-derived peptides in atherosclerosis-prone mice found dose-dependent reductions in oxidized LDL (down roughly 13% at low doses and 39% at high doses), along with lower levels of reactive oxygen species and reduced accumulation of inflammatory macrophages in arterial lesions. The inflammatory cytokines that drive plaque instability also fell.¹⁸ This suggests kefir’s cardiovascular relevance may extend beyond what a standard lipid panel captures.

The human trial in women with metabolic syndrome supports this to some degree. It reported reductions not only in LDL cholesterol but also in oxidized LDL specifically, alongside lower blood pressure and fasting blood sugar.¹ If kefir’s oxidized LDL-lowering effect holds up in larger studies, that would be arguably more important than its modest effects on total LDL, since oxidized LDL is more directly involved in the atherosclerotic process.

Cardiovascular disease is driven by a web of interacting factors: inflammation, oxidative stress, endothelial dysfunction, insulin resistance, and lipid abnormalities all feed into each other. A food that nudges several of these simultaneously, even modestly, could be more useful than its effect on any single lab value would suggest. That said, no one should treat kefir as a replacement for statins or other medications when those are warranted. The effect sizes in kefir trials are small enough that they belong in the “helpful dietary habit” category rather than the “therapeutic intervention” category.

Water Kefir and Plant-Based Alternatives

People who avoid dairy sometimes ask whether water kefir, made by fermenting sugar water with a different set of grains, offers the same cholesterol benefits. The short answer is that almost no clinical data exists on water kefir and cholesterol specifically. Water kefir grains contain a different microbial community from milk kefir grains, with a heavier emphasis on acetic acid bacteria and fewer of the Lactobacillus species that produce bile salt hydrolase. Water kefir also lacks the dairy matrix, meaning it does not carry the casein-derived peptides and milk fat globule membrane components that may contribute to fermented dairy’s cardiovascular profile. The research on water kefir has focused primarily on antioxidant and anti-inflammatory properties rather than lipid metabolism. If your goal is specifically cholesterol management, milk kefir is the form with actual evidence behind it, limited as that evidence is.

Plant-based kefir alternatives made with coconut, oat, or soy milk are increasingly available, but these have barely been studied at all. The fermentation dynamics change with the substrate, so it would be a mistake to assume that fermenting oat milk with kefir grains produces the same metabolic effects as fermenting cow’s milk. Researchers have not yet caught up with the grocery store on this one.